Literature DB >> 26405602

Enhanced targeting of stem-like solid tumor cells with radiation and natural killer cells.

Erik Ames1, Robert J Canter2, Steven K Grossenbacher1, Stephanie Mac1, Rachel C Smith1, Arta M Monjazeb3, Mingyi Chen4, William J Murphy5.   

Abstract

Natural killer (NK) cells are innate lymphocytes postulated to mediate resistance against primary haematopoietic but not solid tumor malignancies. Cancer stem cells (CSCs) are a small subset of malignant cells with stem-like properties which are resistant to chemo- and radiotherapies and are able to repopulate a tumor after cytoreductive treatments. We observed increased frequencies of stem-like tumor cells after irradiation, with increased expression of stress ligands on surviving stem-like cells. Ex vivo NK cells activated by low dose IL2 in vitro and IL15 in vivo displayed an increased ability to target solid tumor stem-like cells both in vitro and in vivo after irradiation. Mechanistically, both upregulation of stress-related ligands on the stem-like cells as well as debulking of non-stem populations contributed to these effects as determined by data from cell lines, primary tumor samples, and most relevant patient derived specimens. In addition, pretreatment of tumor-bearing mice with local radiation prior to NK transfer resulted in significantly longer survival indicating that radiation therapy in conjunction with NK cell adoptive immunotherapy targeting stem-like cancer cells may offer a promising novel radio-immunotherapy approach in the clinic.

Entities:  

Keywords:  adoptive immunotherapy; cancer stem cell; natural killer cells; radiotherapy

Year:  2015        PMID: 26405602      PMCID: PMC4570100          DOI: 10.1080/2162402X.2015.1036212

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN: 2162-4011            Impact factor:   8.110


  35 in total

1.  Possible involvement of stem-like populations with elevated ALDH1 in sarcomas for chemotherapeutic drug resistance.

Authors:  Kanya Honoki; Hiromasa Fujii; Atsushi Kubo; Akira Kido; Toshio Mori; Yasuhito Tanaka; Toshifumi Tsujiuchi
Journal:  Oncol Rep       Date:  2010-08       Impact factor: 3.906

Review 2.  Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect.

Authors:  Sherif S Farag; Todd A Fehniger; Loredana Ruggeri; Andrea Velardi; Michael A Caligiuri
Journal:  Blood       Date:  2002-09-15       Impact factor: 22.113

3.  Human NK cells selective targeting of colon cancer-initiating cells: a role for natural cytotoxicity receptors and MHC class I molecules.

Authors:  Rossana Tallerico; Matilde Todaro; Simone Di Franco; Cristina Maccalli; Cinzia Garofalo; Rosa Sottile; Camillo Palmieri; Luca Tirinato; Pradeepa N Pangigadde; Rosanna La Rocca; Ofer Mandelboim; Giorgio Stassi; Enzo Di Fabrizio; Giorgio Parmiani; Alessandro Moretta; Francesco Dieli; Klas Kärre; Ennio Carbone
Journal:  J Immunol       Date:  2013-01-23       Impact factor: 5.422

4.  Susceptibility to cytotoxic T cell lysis of cancer stem cells derived from cervical and head and neck tumor cell lines.

Authors:  Tian Liao; Andreas M Kaufmann; Xu Qian; Voramon Sangvatanakul; Chao Chen; Tina Kube; Guoyou Zhang; Andreas E Albers
Journal:  J Cancer Res Clin Oncol       Date:  2012-09-23       Impact factor: 4.553

Review 5.  Advantages and clinical applications of natural killer cells in cancer immunotherapy.

Authors:  Erik Ames; William J Murphy
Journal:  Cancer Immunol Immunother       Date:  2013-08-30       Impact factor: 6.968

6.  ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.

Authors:  Christophe Ginestier; Min Hee Hur; Emmanuelle Charafe-Jauffret; Florence Monville; Julie Dutcher; Marty Brown; Jocelyne Jacquemier; Patrice Viens; Celina G Kleer; Suling Liu; Anne Schott; Dan Hayes; Daniel Birnbaum; Max S Wicha; Gabriela Dontu
Journal:  Cell Stem Cell       Date:  2007-11       Impact factor: 24.633

7.  MYC regulation of CHK1 and CHK2 promotes radioresistance in a stem cell-like population of nasopharyngeal carcinoma cells.

Authors:  Wen-Jun Wang; Si-Pei Wu; Jia-Bin Liu; Yong-Sheng Shi; Xue Huang; Qian-Bing Zhang; Kai-Tai Yao
Journal:  Cancer Res       Date:  2012-12-26       Impact factor: 12.701

8.  Natural killer cell subsets differentially reject embryonic stem cells based on licensing.

Authors:  Jessica Perez-Cunningham; Erik Ames; Rachel C Smith; Anna K Peter; Ridhima Naidu; Jan A Nolta; William J Murphy
Journal:  Transplantation       Date:  2014-05-27       Impact factor: 4.939

9.  ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma.

Authors:  Michael P Kim; Jason B Fleming; Huamin Wang; James L Abbruzzese; Woonyoung Choi; Scott Kopetz; David J McConkey; Douglas B Evans; Gary E Gallick
Journal:  PLoS One       Date:  2011-06-13       Impact factor: 3.240

10.  Aldehyde dehydrogenase 1, a potential marker for cancer stem cells in human sarcoma.

Authors:  Birgit Lohberger; Beate Rinner; Nicole Stuendl; Markus Absenger; Bernadette Liegl-Atzwanger; Sonja M Walzer; Reinhard Windhager; Andreas Leithner
Journal:  PLoS One       Date:  2012-08-23       Impact factor: 3.240

View more
  34 in total

Review 1.  Of Cytometry, Stem Cells and Fountain of Youth.

Authors:  Dariusz Galkowski; Mariusz Z Ratajczak; Janusz Kocki; Zbigniew Darzynkiewicz
Journal:  Stem Cell Rev Rep       Date:  2017-08       Impact factor: 5.739

Review 2.  Radiotherapy and immunotherapy: a beneficial liaison?

Authors:  Ralph R Weichselbaum; Hua Liang; Liufu Deng; Yang-Xin Fu
Journal:  Nat Rev Clin Oncol       Date:  2017-01-17       Impact factor: 66.675

Review 3.  Challenges of NK cell-based immunotherapy in the new era.

Authors:  Fang Fang; Weihua Xiao; Zhigang Tian
Journal:  Front Med       Date:  2018-07-25       Impact factor: 4.592

Review 4.  Therapeutic targeting of gastrointestinal cancer stem cells.

Authors:  Jonathan Stem; John C Flickinger; Dante Merlino; Ellen M Caparosa; Adam E Snook; Scott A Waldman
Journal:  Regen Med       Date:  2019-04-26       Impact factor: 3.806

5.  Alterations in cancer stem-cell marker CD44 expression predict oncologic outcome in soft-tissue sarcomas.

Authors:  Timothy Henderson; Mingyi Chen; Morgan A Darrow; Chin-Shang Li; Chi-Lu Chiu; Arta M Monjazeb; William J Murphy; Robert J Canter
Journal:  J Surg Res       Date:  2017-12-22       Impact factor: 2.192

Review 6.  Leveraging natural killer cells for cancer immunotherapy.

Authors:  Steven K Grossenbacher; Ethan G Aguilar; William J Murphy
Journal:  Immunotherapy       Date:  2017-05       Impact factor: 4.196

Review 7.  Targeting Cancer Stem Cells with Natural Killer Cell Immunotherapy.

Authors:  Jesus I Luna; Steven K Grossenbacher; William J Murphy; Robert J Canter
Journal:  Expert Opin Biol Ther       Date:  2016-12-23       Impact factor: 4.388

8.  Stereotactic Ablative Radiation Therapy Induces Systemic Differences in Peripheral Blood Immunophenotype Dependent on Irradiated Site.

Authors:  Heather M McGee; Megan E Daly; Sohelia Azghadi; Susan L Stewart; Leslie Oesterich; Jeffrey Schlom; Renee Donahue; Jonathan D Schoenfeld; Qian Chen; Shyam Rao; Ruben C Fragoso; Richard K Valicenti; Robert J Canter; Emmanual M Maverakis; William J Murphy; Karen Kelly; Arta M Monjazeb
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-04-22       Impact factor: 7.038

Review 9.  Effects of Radiation on the Tumor Microenvironment.

Authors:  Arta M Monjazeb; Kurt A Schalper; Franz Villarroel-Espindola; Anthony Nguyen; Stephen L Shiao; Kristina Young
Journal:  Semin Radiat Oncol       Date:  2020-04       Impact factor: 5.934

Review 10.  There and back again: Translating adoptive cell therapy to canine cancer and improving human treatment.

Authors:  Samuel A Brill; Douglas H Thamm
Journal:  Vet Comp Oncol       Date:  2021-07-18       Impact factor: 2.385

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.